News and Events
Fishawack Health enhances its omnichannel offering with the acquisition of analytics-driven digital marketing agency, closerlook
As part of its bold growth plans, Fishawack Health announces the acquisition of closerlook, a data analytics and digital native healthcare agency specializing in intelligent omnichannel marketing solutions.
Fishawack Health, a leading global commercialization partner for the life sciences industry, announces the acquisition of Chicago-based closerlook LLC. closerlook is a digital-native healthcare agency that leverages artificial intelligence (AI) and data analytics to develop omnichannel strategies, creative and digital media solutions for life science brands across the entire pre-commercial and commercial lifecycle of a drug.
The award-winning firm’s skills and software products in data science, AI and advanced analytics provide life science brands with real-time insights, providing the ability to develop hyper-targeted and precisely personalized campaigns at scale. This expertise, combined with Fishawack Health’s broad spectrum of medical communications, commercial and consulting capabilities, will provide healthcare marketers with unrivaled access to an integrated platform that is designed for competitive advantage.
closerlook’s approach to data-driven healthcare marketing is powered by its four interlocking capabilities: omnichannel strategy, conceptual creative and content, digital tactics and media management, and advanced analytics. These are all informed by Backstage® Intelligence, the firm’s proprietary data and intelligence market hub. The platform uses AI and data science to inform and precisely tailor healthcare professional and patient experiences. Such personalization ensures biopharma companies engage with customers and patients in novel and intelligent ways, driving innovation, and connecting healthcare professionals and patients with the knowledge they need to improve health outcomes and live better lives.
Oliver Dennis, Fishawack Health co-founder, and CEO said: “Traditionally, the healthcare sector has fallen behind when it comes to leveraging the power of innovative technologies to enhance commercial and medical communications strategies. The COVID-19 pandemic has highlighted the necessity of digital communication and the opportunities an omnichannel approach brings. Life science brands need a new breed of partner that offers bespoke teams who bring with them digital and analytics prowess, a rigorous understanding of the science, and the ability to develop impactful strategies and creative solutions.
“Importantly, closerlook’s advanced AI and analytics offering can track and optimize performance, delivering increased business results for clients. Through this combination of expertise, we can develop highly intelligent solutions that are integral for developing, launching, and growing brands and portfolios in a complex and crowded marketplace.”
Life science brands need a new breed of partner that offers bespoke teams who bring with them digital and analytics prowess, a rigorous understanding of the science, and the ability to develop impactful strategies and creative solutions.– Oliver Dennis, Fishawack Health co-founder and CEO
David Ormesher, CEO of closerlook, said: “We are energized by the prospect of joining a global team with the breadth and depth of Fishawack Health. I believe that the combination of our AI/advanced analytics-enabled omnichannel strategy, creative, and digital media with Fishawack Health’s global consulting, commercial and medical communications capabilities will create a unique commercialization offering for life science brands and healthcare companies looking for growth.”
“We have spent over six months getting to know the Fishawack Health leadership, and we are excited about the alignment of vision, purpose, and culture between our two organizations. Over the past year, closerlook has experienced the fastest growth in its history and we expect Fishawack Health to supercharge that even more. We are looking forward to working together to achieve our mission of better health outcomes for patients and greater business results for the biopharma brands that serve them.”
Fishawack Health Group President Gail Flockhart said: “We are delighted to welcome closerlook to Fishawack Health, including their impressive and experienced management team who will no doubt play an important role in helping us further enhance our capabilities and services across the group.”
About Fishawack Health
Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in the UK, the organization is powered by a 1,100+ globe-spanning pack of strategic, creative, and scientific experts. We aim to drive change with HCPs and affect patient lives.
Our three core operating units – Medical Communications, Consulting, and Commercial – bring together best-in-class capabilities from around the world. We empower our clients in global pharmaceuticals, innovative biotech, and medical devices to navigate the most complex of ecosystems while embarking on a faster, more efficient path to developing, launching, and growing their brands and portfolios.
Our internationally recognized, award-winning teams collaborate across operations in the UK (Brighton, Fleet, London, Knutsford, Manchester, Oxford, and Sale), Ireland (Dublin), USA (Evansville, Minneapolis, New York, Philadelphia, San Diego, Scottsdale, and St. Louis), Greece (Athens), and Singapore.
Visit us at www.fishawack.com and follow us on Twitter and LinkedIn.
Want to learn more about digital health trends? Download Fishawack Health’s Delta magazine
More from closerlook
Unlocking Hope for Patients with Rare Diseases
CEO David Ormesher has hope for the future of rare diseases. Read about how data science and digital transformation will unlock new drugs for patients.Read more
Backstage® Relate featured in PM360 Innovations Issue
Building relationships between a biopharma brand and target HCPs is typically a long-term commitment. But what if that relationship building process could be accelerated?Read More